Peptide Synthesis Market Size, Share, Growth Analysis, By Product (Equipment, Peptide Synthesizers), By Technology (Solid Phase Peptide Synthesis, Liquid Phase Peptide Synthesis), By Application (Personalized Therapeutics, Cancer, Metabolic), By End-use, By Region - Industry Forecast 2024-2031.

North America is dominating the global peptide synthesis market due to higher healthcare expenditure and developed healthcare service offerings. North America is home to some of the largest pharmaceutical companies in the world. These players are investing significantly in R&D with the cumulative R&D cost of the pharmaceutical companies in the US accounting to more than USD 95 billion in 2023. The increasing prevalence of chronic diseases in North America is also increasing the demand for peptide synthesis in the region. In the US, more than half of the adult population was reported to suffer from at least one chronic disease.

Demand for peptide synthesis is expected to grow the fastest in the Asia Pacific region. Asia Pacific region is the hub of contract manufacturing for pharmaceutical companies. Developing companies in the region such as China and India are investing significantly on providing facility and infrastructure for contract manufacturing. In addition, availability of trained human resources and the cheaper cost involved in approval and development of peptide synthesis is expected to fuel the demand for market during the forecast period. Growing healthcare budget and improving healthcare insurance coverage in developing economies in the region is also driving the end use demand.